专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20070280903A1 T1 Receptor-Like Ligand II and Uses Thereof 审中-公开
标题翻译： T1受体样配体II及其用途
公开(公告)号：US20070280903A1
公开(公告)日：2007-12-06
申请号：US11554432
申请日：2006-10-30
申请人： Jian Ni , Reiner Gentz , Steven Ruben
发明人： Jian Ni , Reiner Gentz , Steven Ruben
IPC分类号： A61K38/19 , A61K38/17 , C12Q1/68 , A61K38/18
CPC分类号： G01N33/564 , A61K38/1709 , A61K38/20 , A61K45/06 , A61K48/00 , C07K14/54 , C12N2799/026 , G01N33/57407 , G01N33/57426 , G01N33/6893 , G01N33/6896 , G01N2800/24 , G01N2800/2821 , G01N2800/368
摘要： The present invention relates to a novel T1 Receptor (T1R)-like ligand II protein. In particular, isolated nucleic acid molecules are provided encoding the T1R-like ligand II protein. T1R-like ligand II polypeptides are also provided, as are recombinant vectors and host cells for expressing the same. This invention further relates to pharmaceutical compositions and formulations comprising T1R-like ligand II. Also provided are methods of using T1R-like ligand II polynucleotides, polypeptides, antibodies or agonists/antagonists for therapeutic and diagnostic purposes. Diagnostic kits are further provided.
摘要翻译：本发明涉及一种新颖的T1受体（T1R）样配体II蛋白。特别地，提供编码T1R样配体II蛋白质的分离的核酸分子。还提供了T1R样配体II多肽，重组载体和用于表达它们的宿主细胞也是如此。本发明还涉及包含T1R样配体II的药物组合物和制剂。还提供了用于治疗和诊断目的的T1R样配体II多核苷酸，多肽，抗体或激动剂/拮抗剂的方法。还提供诊断试剂盒。

2. 发明申请

US20070238130A1 Novel Metalloproteinases 审中-公开
标题翻译：新型金属蛋白酶
公开(公告)号：US20070238130A1
公开(公告)日：2007-10-11
申请号：US11627246
申请日：2007-01-25
申请人： Jian Ni , Steven Ruben , Laurie Brewer , Reiner Gentz , Craig Rosen
发明人： Jian Ni , Steven Ruben , Laurie Brewer , Reiner Gentz , Craig Rosen
IPC分类号： C12P1/04 , C07H21/04 , C07K14/00 , C07K16/18 , G01N33/53 , C12N15/00 , C12N5/06
CPC分类号： C12N9/6489 , A61K38/00 , C07K14/47 , C07K14/705 , C07K14/70535 , C12N9/00 , C12N9/6475 , C12N9/6491 , C12N2799/026
摘要： The present invention relates to novel metalloproteinase- like proteins. In particular, isolated nucleic acid molecules are provided encoding the human TACE-like and matrilysin-like proteins. TACE-like and matrilysin-like polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TACE-like and matrilysin-like activity. Also provided are diagnostic methods for detecting cancer and therapeutic methods for cancer and other disorders characterized by an over or under production of these metalloproteinases.
摘要翻译：本发明涉及新型金属蛋白酶样蛋白质。特别地，提供了分离的核酸分子，其编码人类TACE样和基质溶素样蛋白。 TACE样和基质溶素样多肽也可以作为载体，宿主细胞和用于制备它们的重组方法提供。本发明进一步涉及用于鉴定TACE样和基质溶素样活性的激动剂和拮抗剂的筛选方法。还提供了用于检测癌症的诊断方法和癌症的治疗方法以及特征在于这些金属蛋白酶过度或过量生产的其它病症。

3. 发明申请

US20060063924A1 Leukocyte regulatory factors 1 and 2 审中-公开
标题翻译：白细胞调节因子1和2
公开(公告)号：US20060063924A1
公开(公告)日：2006-03-23
申请号：US11272833
申请日：2005-11-15
申请人： Jian Ni , Jing-Shan Hu , Steven Ruben , Reiner Gentz
发明人： Jian Ni , Jing-Shan Hu , Steven Ruben , Reiner Gentz
IPC分类号： C07K14/475 , C07H21/02 , C12P21/06
CPC分类号： C07K14/4702
摘要： The present invention relates to novel LRF-1 and LRF-2 proteins which are related to the CRISP family and a protein called “Neutrophil Inhibitory Factor (NIF)” isolated from the canine hookworm (Ancylostoma caninum) that potently inhibits CD11/CD18-dependent neutrophil function. In particular, isolated nucleic acid molecules are provided encoding the human LRF-1 and LRF-2 proteins. LRF-1 and LRF-2 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of LRF-1 or LRF-2 activity. Also provided are diagnostic methods for detecting immune system or other LRF-1- or LRF-2-related disorders and therapeutic methods for treating such disorders.
摘要翻译：本发明涉及与CRISP家族相关的新型LRF-1和LRF-2蛋白质，以及从犬钩虫（Ancylostoma caninum）中分离的称为“中性嗜中性粒细胞抑制因子（NIF）”的蛋白质，其有效抑制CD11 / CD18依赖性中性粒细胞功能。特别地，提供编码人LRF-1和LRF-2蛋白的分离的核酸分子。还提供了LRF-1和LRF-2多肽，载体，宿主细胞以及用于制备它们的重组方法也是如此。本发明还涉及用于鉴定LRF-1或LRF-2活性的激动剂和拮抗剂的筛选方法。还提供了用于检测免疫系统或其他LRF-1或LRF-2相关疾病的诊断方法以及用于治疗这种疾病的治疗方法。

4. 发明申请

US20050255100A1 Antibodies to tumor necrosis factor receptor 5 失效
标题翻译：肿瘤坏死因子受体5的抗体
公开(公告)号：US20050255100A1
公开(公告)日：2005-11-17
申请号：US11182946
申请日：2005-07-18
申请人： Ying-Fei Wei , Jian Ni , Reiner Gentz , Steven Ruben
发明人： Ying-Fei Wei , Jian Ni , Reiner Gentz , Steven Ruben
IPC分类号： A61K31/522 , A61K31/66 , A61K38/00 , A61K38/13 , A61K38/17 , A61K38/19 , A61K38/20 , A61K38/21 , A61K39/395 , A61K45/06 , A61K48/00 , C07K14/705 , C07K16/28
CPC分类号： A61K31/522 , A61K31/66 , A61K39/395 , A61K45/06 , A61K48/00 , A61K2039/505 , C07K14/70578 , C07K16/2878 , C07K2319/00 , C07K2319/30 , C12N2799/026 , A61K2300/00
摘要： The present invention relates to a novel human gene encoding a polypeptide which is a member of the TNF receptor family, and has now been found to bind TRAIL. More specifically, an isolated nucleic acid molecule is provided encoding a human polypeptide named tumor necrosis factor receptor-5, sometimes referred to as “TNFR-5” or “TR5,” and now referred to hereinafter as “TRAIL receptor without intracellular domain” or “TRID.” TRID polypeptides are also provided, as are vectors, host cells, and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists or antagonists of TRAIL polypeptide activity. Also provided are diagnostic and therapeutic methods utilizing such compositions.
摘要翻译：本发明涉及编码作为TNF受体家族成员的多肽的新型人基因，现已发现其结合TRAIL。更具体地，提供编码称为肿瘤坏死因子受体-5（有时称为“TNFR-5”或“TR5”）的人多肽的分离的核酸分子，以下在下文中称为“没有细胞内结构域的TRAIL受体”或 “TRID”。还提供了TRID多肽，载体，宿主细胞以及用于制备它们的重组方法也是如此。本发明还涉及用于鉴定TRAIL多肽活性的激动剂或拮抗剂的筛选方法。还提供了利用这种组合物的诊断和治疗方法。

5. 发明申请

US20060234285A1 Tumor Necrosis Factor Receptors 6 Alpha & 6 Beta 审中-公开
标题翻译：肿瘤坏死因子受体6 Alpha＆6 Beta
公开(公告)号：US20060234285A1
公开(公告)日：2006-10-19
申请号：US11419656
申请日：2006-05-22
申请人： Reiner Gentz , Guo-Liang Yu , Jian Ni , Reinhard Ebner , Ping Feng , Steven Ruben
发明人： Reiner Gentz , Guo-Liang Yu , Jian Ni , Reinhard Ebner , Ping Feng , Steven Ruben
IPC分类号： C12Q1/68 , G01N33/574 , A61K38/17 , C07H21/04 , C12P21/06 , C07K14/715
CPC分类号： G01N33/57488 , A61K38/00 , C07K14/70578 , C07K14/7151
摘要： The present invention relates to novel Tumor Necrosis Factor Receptor proteins. In particular, isolated nucleic acid molecules are provided encoding the human TNFR-6α & -6β proteins. TNFR-6α & -6β polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TNFR-6α & -6β activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.
摘要翻译：本发明涉及新型肿瘤坏死因子受体蛋白。特别地，提供编码人TNFR-6α和-6β蛋白的分离的核酸分子。还提供了TNFR-6α和-6β多肽，载体，宿主细胞和用于制备它们的重组方法。本发明还涉及鉴定TNFR-6α和-6β活性的激动剂和拮抗剂的筛选方法。还提供了用于检测免疫系统相关疾病的诊断方法和用于治疗免疫系统相关疾病的治疗方法。

6. 发明申请

US20060045878A1 Pancreas-derived plasminogen activator inhibitor 审中-公开
标题翻译：胰腺来源的纤溶酶原激活物抑制剂
公开(公告)号：US20060045878A1
公开(公告)日：2006-03-02
申请号：US11048774
申请日：2005-02-03
申请人： Jian Ni , Reiner Gentz , Steven Ruben , Y. Shi
发明人： Jian Ni , Reiner Gentz , Steven Ruben , Y. Shi
IPC分类号： C07H21/04 , A61K39/395 , C07K16/44 , C12N5/06
CPC分类号： C07K14/81 , A61K38/00 , A61K48/00 , C07K14/8132 , C07K2319/00 , Y02A50/463
摘要： The present invention relates to a novel member of the plasminogen activator inhibitor protein family. In particular, isolated nucleic acid molecules are provided encoding the pancreas-derived plasminogen activator inhibitor protein. Pancreas-derived plasminogen activator inhibitor polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to methods for treating physiologic and pathologic disease conditions and diagnostic methods for detecting pathologic disorders.
摘要翻译：本发明涉及纤溶酶原激活物抑制剂蛋白家族的新成员。特别地，提供编码胰腺衍生的纤溶酶原激活物抑制蛋白的分离的核酸分子。还提供了胰腺来源的纤溶酶原激活物抑制剂多肽，载体，宿主细胞和用于制备它们的重组方法。本发明还涉及用于治疗生理和病理疾病状况的方法以及用于检测病理学疾病的诊断方法。

7. 发明申请

US20050037966A1 Keratinocyte growth factor-2 审中-公开
标题翻译：角质形成细胞生长因子-2
公开(公告)号：US20050037966A1
公开(公告)日：2005-02-17
申请号：US10901210
申请日：2004-07-29
申请人： Steven Ruben , Pablo Jimenez , Roxanne Duan , Mark Rampy , Donna Mendrick , Jun Zhang , Jian Ni , Paul Moore , Timothy Coleman , Joachim Gruber , Patrick Dillon , Reiner Gentz
发明人： Steven Ruben , Pablo Jimenez , Roxanne Duan , Mark Rampy , Donna Mendrick , Jun Zhang , Jian Ni , Paul Moore , Timothy Coleman , Joachim Gruber , Patrick Dillon , Reiner Gentz
IPC分类号： A61K38/00 , A61K48/00 , C07K14/50 , C12N5/08 , A61K38/18 , C07K14/475
CPC分类号： C07K14/50 , A01K2217/05 , A01K2217/075 , A61K38/00 , A61K48/00
摘要： This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptide of the present invention is a Keratinocyte Growth Factor, sometimes hereinafter referred to as “KGF-2” also formerly known as Fibroblast Growth Factor 12 (FGF-12). This invention further relates to the therapeutic use of KGF-2 to promote or accelerate wound healing. This invention also relates to novel mutant forms of KGF-2 that show enhanced activity, increased stability, higher yield or better solubility.
摘要翻译：本发明涉及新鉴定的多核苷酸，由这种多核苷酸编码的多肽，这种多核苷酸和多肽的用途，以及这种多核苷酸和多肽的产生。更具体地，本发明的多肽是角质形成细胞生长因子，有时在下文中称为“KGF-2”，以前称为成纤维细胞生长因子12（FGF-12）。本发明还涉及KGF-2促进或加速伤口愈合的治疗用途。本发明还涉及显示增强的活性，增加的稳定性，更高的产量或更好的溶解度的KGF-2的新型突变形式。

8. 发明申请

US20060193861A1 Tumor necrosis factor receptors 6 alpha & 6 beta 有权
标题翻译：肿瘤坏死因子受体6α和6β
公开(公告)号：US20060193861A1
公开(公告)日：2006-08-31
申请号：US11416310
申请日：2006-05-03
申请人： Reiner Gentz , Reinhard Ebner , Guo-Liang Yu , Steven Ruben , Jian Ni , Ping Feng
发明人： Reiner Gentz , Reinhard Ebner , Guo-Liang Yu , Steven Ruben , Jian Ni , Ping Feng
IPC分类号： A61K39/395 , C07H21/04 , C12P21/06 , C07K16/24 , C12N1/18 , C12N5/06
CPC分类号： A61K48/005 , A61K38/00 , A61K48/0058 , C07K14/4703 , C07K14/70578 , C07K14/7151 , C07K2319/00 , C07K2319/30 , C12Q1/6883 , C12Q2600/156 , C12Q2600/158
摘要： The present invention relates to novel Tumor Necrosis Factor Receptor proteins. In particular, isolated nucleic acid molecules are provided encoding the human TNFR-6α & -6β proteins. TNFR-6α & -6β polypeptides and antibodies that bind TNFR-6α & -6β polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TNFR-6α & -6β activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.
摘要翻译：本发明涉及新型肿瘤坏死因子受体蛋白。特别地，提供编码人TNFR-6α和-6β蛋白的分离的核酸分子。还提供TNFR-6α和-6β多肽和结合TNFR-6α和-6β多肽的抗体，载体，宿主细胞和用于制备它们的重组方法。本发明还涉及鉴定TNFR-6α和-6β活性的激动剂和拮抗剂的筛选方法。还提供了用于检测免疫系统相关疾病的诊断方法和用于治疗免疫系统相关疾病的治疗方法。

9. 发明授权

US07393943B1 Polynucleotides encoding a human chemotactic cytokine I 失效
标题翻译：编码人趋化因子I的多核苷酸
公开(公告)号：US07393943B1
公开(公告)日：2008-07-01
申请号：US08761289
申请日：1996-12-06
申请人： Jian Ni , Guo-Liang Yu , Pedro Alfonso , Reiner Gentz , Jeffrey Y. Su
发明人： Jian Ni , Guo-Liang Yu , Pedro Alfonso , Reiner Gentz , Jeffrey Y. Su
IPC分类号： C07H21/04 , C12P21/06 , C12N1/20 , C12N15/00 , C12N5/00 , C12N5/02 , C12N15/74
CPC分类号： C07K14/52 , C07H21/04
摘要： Human chemotactic cytokine I polypeptides and DNA (RNA) encoding such chemotactic cytokines and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemotactic cytokines for the treatment of leukemia, tumors, chronic infections, auto-immune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemotactic cytokines and their use as a therapeutic to treat rheumatoid arthritis, auto-immune and chronic and acute inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the chemotactic cytokines and for detecting altered levels of the polypeptide in a host.
摘要翻译：公开了人类趋化性细胞因子I多肽和编码这种趋化性细胞因子的DNA（RNA）以及通过重组技术产生此类多肽的方法。还公开了利用这种趋化性细胞因子治疗白血病，肿瘤，慢性感染，自身免疫疾病，纤维化病症，伤口愈合和牛皮癣的方法。还公开了抗这种趋化性细胞因子的拮抗剂及其作为治疗类风湿性关节炎，自身免疫，慢性和急性炎性和感染性疾病，过敏反应，前列腺素不依赖性发烧和骨髓衰竭的治疗剂的用途。还公开了用于检测与核酸序列中的突变和多肽的改变的浓度相关的疾病的诊断测定。还公开了用于检测编码趋化性细胞因子的多核苷酸中的突变并用于检测宿主中多肽的改变水平的诊断测定。

10. 发明申请

US20080015149A1 Galectin 11 审中-公开
标题翻译：半乳凝素11
公开(公告)号：US20080015149A1
公开(公告)日：2008-01-17
申请号：US11773491
申请日：2007-07-05
申请人： Jian Ni , Reiner Gentz , Craig Rosen , Fu-Tong Lui
发明人： Jian Ni , Reiner Gentz , Craig Rosen , Fu-Tong Lui
IPC分类号： A61K38/17 , A61P11/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/08 , C07H21/04 , C07K14/435 , C07K16/18 , C12N15/63 , C12N5/10 , C12P21/00 , G01N33/53
CPC分类号： C12N9/6475 , A61K38/00 , A61K2039/505 , C07K14/47 , C07K14/4726 , C07K14/705 , C07K14/70535 , C07K16/18 , C07K16/2851 , C12N9/6489 , C12N9/6491 , C12N2799/026
摘要： The present invention relates to novel galectin 11 proteins which are members of the galectin superfamily. In particular, isolated nucleic acid molecules are provided encoding the human galectin 11 proteins. Galectin 11 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of galectin 11 activity. Also provided are diagnostic and therapeutic methods.
摘要翻译：本发明涉及作为半乳凝素超家族成员的新型半乳凝素11蛋白。特别地，提供了分离的核酸分子，其编码人galectin11蛋白。还提供了Galectin11多肽，载体，宿主细胞和用于制备它们的重组方法。本发明进一步涉及用于鉴定galectin11活性的激动剂和拮抗剂的筛选方法。还提供诊断和治疗方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式